Literature DB >> 2542706

Hepatocellular carcinoma: molecular biology of its growth and relationship to hepatitis B virus infection.

A M Di Bisceglie1.   

Abstract

Hepatocellular carcinoma is a very common tumor worldwide and is associated with high mortality rates. Evidence that the development of hepatocellular carcinoma is related to chronic HBV infection has accumulated from epidemiologic studies, information from animal and cell culture models, and molecular biologic evidence that HBV components can be found within hepatocellular carcinoma tissue. Integration of HBV DNA within host liver cell chromosomes may be a crucial step in the development of hepatocellular carcinoma. Integration is associated with disruption of both structure and function of DNA at the site of integration. The study of individual examples of HBV DNA integration in hepatocellular carcinoma tissue illustrates possible mechanisms of hepatocarcinogenesis by HBV. In many cases, activation of various growth factors has been found in association with HBV DNA integration including IGF II, oncogenes such as c-myc, and novel growth factors such as the retinoic acid receptor. A clearer understanding of the mechanisms involved may allow for possible therapeutic interventions in the future, or perhaps even the prevention of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542706     DOI: 10.1016/s0025-7125(16)30649-6

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  16 in total

Review 1.  Therapeutic management algorithm in cirrhotic and noncirrhotic patients in primary or secondary liver masses.

Authors:  Eldo Ermenegildo Frezza
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

2.  Alterations of glycan branching and differential expression of sialic acid on alpha fetoprotein among hepatitis patients.

Authors:  Gautam Mondal; Urmimala Chatterjee; Yogesh K Chawla; Bishnu Pada Chatterjee
Journal:  Glycoconj J       Date:  2010-12-14       Impact factor: 2.916

3.  Total serum glycan analysis is superior to lectin-FLISA for the early detection of hepatocellular carcinoma.

Authors:  Mary Ann Comunale; Mengjun Wang; Nikhil Anbarasan; Lucy Betesh; Aykan Karabudak; Ethan Moritz; Karthik Devarajan; Jorge Marrero; Timothy M Block; Anand Mehta
Journal:  Proteomics Clin Appl       Date:  2013-09-13       Impact factor: 3.494

4.  Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients.

Authors:  S A Curley; F Izzo; P Delrio; L M Ellis; J Granchi; P Vallone; F Fiore; S Pignata; B Daniele; F Cremona
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

Review 5.  Immunological treatment of liver tumors.

Authors:  Maurizio Chiriva-Internati; Fabio Grizzi; Cynthia A Jumper; Everardo Cobos; Paul L Hermonat; Eldo E Frezza
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

6.  Novel changes in glycosylation of serum Apo-J in patients with hepatocellular carcinoma.

Authors:  Mary Ann Comunale; Mengjun Wang; Lucy Rodemich-Betesh; Julie Hafner; Anne Lamontagne; Andrew Klein; Jorge Marrero; Adrian M Di Bisceglie; Robert Gish; Timothy Block; Anand Mehta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-05       Impact factor: 4.254

Review 7.  Biological treatment for liver tumor and new potential biomarkers.

Authors:  Maurizio Chiriva-Internati; Fabio Grizzi; Mitchell S Wachtel; Marjorie Jenkins; Raffaele Ferrari; Everardo Cobos; Eldo E Frezza
Journal:  Dig Dis Sci       Date:  2007-08-22       Impact factor: 3.199

8.  Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.

Authors:  Mary Ann Comunale; Lucy Rodemich-Betesh; Julie Hafner; Mengjun Wang; Pamela Norton; Adrian M Di Bisceglie; Timothy Block; Anand Mehta
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

9.  Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma.

Authors:  Mengjun Wang; Ronald E Long; Mary Ann Comunale; Omer Junaidi; Jorge Marrero; Adrian M Di Bisceglie; Timothy M Block; Anand S Mehta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05-19       Impact factor: 4.254

10.  Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.

Authors:  Gautam Mondal; Ashish Saroha; Partha Pratim Bose; B P Chatterjee
Journal:  Glycoconj J       Date:  2016-03-31       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.